美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=TENOFOVIR ALAFENAMIDE"
符合检索条件的记录共 39 条
共 2 页，当前第 2 页
首页 上一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 002 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 200MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 003 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 25MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 004 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 30MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 005 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 120MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 006 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 15MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
TENOFOVIR ALAFENAMIDE FUMARATE 214030 001 ANDA TENOFOVIR ALAFENAMIDE FUMARATE TABLET;ORAL EQ 25MG BASE No No 2025/08/22 (TA) -- LAURUS LABS LTD None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211680 001 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET 200MG/25MG No No 2025/10/10 (TA) -- CIPLA LIMITED None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 002 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 200MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 003 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 25MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 004 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 30MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 005 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 120MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 006 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 15MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE 214095 001 ANDA EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE TABLET;ORAL 200MG;EQ 25MG BASE;EQ 25MG BASE No No 2026/01/30 2026/01/30 APOTEX Prescription
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218575 002 ANDA ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 150MG No No 2026/02/09 (TA) -- APOTEX INC None (Tentative Approval)
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218575 003 ANDA ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 200MG No No 2026/02/09 (TA) -- APOTEX INC None (Tentative Approval)
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218575 004 ANDA ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 6MG No No 2026/02/09 (TA) -- APOTEX INC None (Tentative Approval)
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218575 005 ANDA ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 90MG No No 2026/02/09 (TA) -- APOTEX INC None (Tentative Approval)
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218575 006 ANDA ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 120MG No No 2026/02/09 (TA) -- APOTEX INC None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE 214216 001 ANDA EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE TABLET;ORAL 200MG;EQ 25MG BASE No No 2026/04/07 2026/04/07 MACLEODS PHARMS LTD Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2026 DrugFuture->U.S. FDA Drugs Database